The treatment of depression is a comprehensive system project aimed at alleviating symptoms, restoring patients' daily functioning, and preventing relapse. Modern medicine employs various methods such as pharmacotherapy, psychotherapy, social support, and lifestyle adjustments, creating personalized plans based on individual patient differences. The key to treatment is early intervention, continuous monitoring of patient responses and side effects, and adjusting strategies according to changes in the condition.
Treatment pathways typically follow a "stepwise principle," first assessing the severity of the patient's symptoms and comorbid conditions, and then selecting an appropriate starting plan. Mild to moderate patients may primarily use psychotherapy, while severe cases may require a combination of medication and psychotherapy. Treatment effectiveness needs to be observed for at least 6 to 8 weeks, and physicians will adjust the treatment combination based on improvement and educate patients and families about common challenges and coping methods during the treatment process.
Current mainstream treatments are divided into three major parts: pharmacotherapy, psychotherapy, and physical therapy. Pharmacotherapy primarily targets neurotransmitter imbalances, psychotherapy focuses on adjusting cognitive and behavioral patterns, and physical therapy, such as transcranial magnetic stimulation (TMS), regulates specific areas of the brain. These can be used alone or in combination; for example, moderate to severe patients often combine antidepressants with cognitive behavioral therapy (CBT).
Treatment choices must consider the patient's age, comorbid diseases, history of drug allergies, and personal preferences. For instance, elderly patients may need dosage adjustments due to lower metabolic rates, while those with a history of heart disease should avoid certain tricyclic antidepressants. In terms of psychotherapy, exposure therapy is particularly effective for patients with accompanying anxiety symptoms, while mindfulness-based stress reduction (MBSR) is suitable for cases with clear stressors.
Selective serotonin reuptake inhibitors (SSRIs) are currently the most common first-line medications, including fluoxetine and sertraline. These drugs target the serotonin system, with side effects including dry mouth, nausea, and sexual dysfunction, but they are generally safer than traditional medications. Second-line medications such as serotonin-norepinephrine reuptake inhibitors (SNRIs), like venlafaxine, are more effective for patients with accompanying anxiety symptoms.
Pharmacotherapy must strictly adhere to the "weekly efficacy principle," as the effects usually take 4 to 6 weeks to manifest. Physicians will assess symptom changes every two weeks during the initial treatment phase. The starting dosage is typically half the standard dose, which is adjusted to the standard dose once the body adapts. When discontinuing medication, the dosage must be gradually reduced, as abruptly stopping SSRIs may trigger withdrawal symptoms such as dizziness and headaches.
Cognitive behavioral therapy (CBT) helps patients establish positive behavioral patterns by challenging negative thinking patterns. Research shows that the effectiveness of CBT in preventing relapse of depression can last for over 5 years. Motivational interviewing (MI) is suitable for patients resistant to treatment, enhancing treatment participation through a non-authoritative dialogue approach.
Mindfulness-based stress reduction (MBSR) reduces the overactivity of the brain's "default mode network" through mindfulness meditation training, with studies showing a reduction in depression relapse rates by up to 30%. Group psychotherapy can provide social support, especially in cases of depression caused by workplace stress or interpersonal relationship issues.
A regular sleep cycle is crucial for recovery from depression. Patients are advised to go to bed and wake up at fixed times daily, avoid caffeine intake in the afternoon, and engage in calming relaxation training before bedtime. Studies indicate that those with regular sleep cycles have a 40% higher treatment efficacy than those with sleep disturbances.
Omega-3 fatty acids and vitamin D deficiency are associated with depression; increasing the intake of deep-sea fish and mushrooms in the diet can improve symptoms. Aerobic exercises like jogging or swimming promote the secretion of brain-derived neurotrophic factor (BDNF), which has an additive effect with pharmacotherapy. It is recommended to engage in 150 minutes of moderate-intensity exercise per week, divided into 5 sessions to enhance sustainability.
Rapid-acting antidepressants such as the ketamine derivative esketamine have been approved for treatment-resistant cases, with mechanisms acting on NMDA receptors that differ significantly from traditional medications. Gene-customized therapy is in development, predicting drug metabolism efficiency through genetic testing, which can shorten the trial-and-error period of medication.
Artificial intelligence-assisted diagnostic systems can analyze patients' speech and text patterns to predict treatment responses. Virtual reality (VR) exposure therapy combined with cognitive behavioral therapy has shown significant effects for depression patients with accompanying panic disorders. Wearable devices, such as heart rate variability analysis bracelets, can track stress indices in real-time, assisting physicians in adjusting treatment plans.
When self-management measures fail to alleviate symptoms for more than 2 weeks, or if there are tendencies for self-harm or severe disruptions in circadian rhythms, immediate evaluation by a psychiatrist should be sought. If a patient has received pharmacotherapy but their Hamilton Rating Scale score has not decreased, or if there are drug interactions or significant side effects (such as QT interval prolongation), the treatment plan needs to be adjusted immediately.
Special populations such as pregnant women, adolescents, or patients with chronic diseases require a treatment plan developed collaboratively by psychiatrists and relevant specialists. For example, patients with a history of heart disease using SNRIs need blood pressure monitoring, and elderly patients should avoid anticholinergic medications to prevent cognitive decline.
Although medications and psychotherapy can be used alone, their combination usually enhances efficacy. Antidepressants can adjust neurotransmitters in the brain, while psychotherapy such as cognitive behavioral therapy helps patients adjust their thinking patterns and behaviors. Physicians will create individualized treatment plans based on the severity of symptoms and personal needs.
How long do antidepressant medications need to be taken to see effects?Antidepressants typically need to be taken continuously for 4 to 6 weeks to show significant effects; some patients may need dosage or medication adjustments. During the treatment period, medications should not be stopped independently, and communication with the physician should be maintained to avoid relapse or withdrawal phenomena.
How can daily life adjustments help alleviate symptoms of depression?Regular exercise (such as 150 minutes of moderate-intensity exercise per week) can promote serotonin secretion in the brain and improve mood. Maintaining a regular routine, a balanced diet (such as increasing Omega-3 fatty acid intake), and establishing a supportive social circle have all been proven to assist in treatment. However, these methods should be combined with professional treatment and cannot replace medical advice.
What should be done about potential side effects of medications during depression treatment?Common initial side effects such as dry mouth, nausea, or drowsiness usually diminish after a few weeks. If symptoms are severe or abnormal reactions such as palpitations or agitation occur, the physician should be notified immediately. The physician may adjust the dosage or switch medications; patients should not stop medications independently and should follow professional advice for gradual adjustments.
Why is continuous follow-up treatment necessary after recovery from depression?Depression has a tendency to recur; even after symptoms have subsided, it is recommended to continue follow-up for 6 months to 2 years. Regular psychological assessments and necessary maintenance medication can reduce the risk of relapse. Physicians will adjust subsequent treatment strategies based on factors such as the patient's life stress and seasonal changes.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
